Ocular Therapeutix, Inc. - OCUL
About Gravity Analytica
Recent News
- 09.30.2025 - Ocular Therapeutix In-Person and Virtual Investor Day 2025
- 09.30.2025 - Ocular Therapeutix In-Person and Virtual Investor Day 2025
- 09.30.2025 - Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
- 09.30.2025 - Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
- 09.30.2025 - Ocular Therapeutix™ Investor Day to Highlight Exceptional AXPAXLI™ Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary Endpoint
- 09.30.2025 - Ocular Therapeutix™ Investor Day to Highlight Exceptional AXPAXLI™ Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary Endpoint
- 09.15.2025 - Daniil Gataulin, PhD
- 09.15.2025 - Daniil Gataulin, PhD
- 09.09.2025 - Baird 2025 Global Healthcare Conference
- 09.09.2025 - Baird 2025 Global Healthcare Conference
Recent Filings
- 09.30.2025 - 8-K Current report
- 09.30.2025 - 8-K Current report
- 09.30.2025 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
- 09.30.2025 - 424B5 Prospectus [Rule 424(b)(5)]
- 09.30.2025 - EX-99.1 EX-99.1
- 09.11.2025 - 4 Statement of changes in beneficial ownership of securities